Pharmaceutical Commerce - March/April 2011

PDR Network plans to incorporate sponsored services like co-pay cards or dosage calculators in the information available to prescribers via EHR interfaces

IMS Health, SDI and Wolters Kluwer make a First Amendment argument for access to physicians’ prescribing information

Generics claim 78% of market; prescriptions dispensed up slightly, but doctor visits decline

Caseload reinforces concerns over illegal trade and distribution of pharmaceuticals

UDP proponents have solid data that demonstrate that this form of packaging maintains better compliance with treatment regimens

Nearly 200 drugs now carry requirements for a risk management program, as FDA evaluates the initial follow-up reporting from manufacturers

Redesigning supply chains could change the shape of bio/pharma

Specialty pharmacies are competing to position themselves as the best partners for manufacturers dealing with high-touch, high-risk products

The recent PDA Cold Chain conference highlighted increased regulatory scrutiny of shipping processes, even while logistics capacity and technology expand

GHX, a major player in med-surg supply management for healthcare providers, looks to extend its e-commerce platform to handling pharma e-pedigrees

The recent acquisition of US Oncology by McKesson highlights the rising importance of the distributor-led networks

Program will seek new legislation while coordinating manufacturing, healthcare-provider and enforcement resources

Logistics provider will purchase BMS’ Mount Vernon, IN facility and build additional capacity in PA

Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake

Industry is falling in love with the Apple iPad. Is it the right move for your company?

New market-research service hopes to quantify trends in outsourced CMOs, CROs and related services

National law won’t stop states from devising their own rules, complicating the IT and compliance task for pharma companies

Healthcare community rebellion brings together compounding pharmacists, FDA and the Orphan Drug Act, and the March of Dimes

Latest J&J McNeil recall again implicates wood pallets

Parent will adapt its national network of 21 facilities to providing sample distribution and marketing services for pharma

Court rules against Zicam maker’s claims of non-materiality

Caseload reinforces concerns over illegal trade and distribution of pharmaceuticals

Intellectual property coordinator assembles enforcement agencies, proposes legislation on Homeland Security to focus on supply chain threats

ValueCentric cited for Safe & Secure Supply Chain IT service